Global Innovative Platforms

Global Innovative Platforms Inc. (GIPL) is an animal health diagnostics company focused on developing non-invasive, breath-based screening technologies for disease detection. The company's core technology, the VOCAM Plus platform, integrates gas chromatography and artificial intelligence to identify disease-specific Volatile Organic Compounds (VOCs) in exhaled breath. Its lead program is a Heartworm Breath Test for dogs, which aims to detect infections significantly earlier than the current industry-standard antigen tests that typically require a six-month maturation window. Headquartered in Florida, GIPL is positioned to expand its diagnostic capabilities into various veterinary diseases and environmental health monitoring to enable earlier clinical intervention and improved animal wellness.